Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    1944469 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty
Conditions: Polyostotic Fibrous Dysplasia;   Precocious Puberty
Intervention: Drug: Testolactone

Indicates status has not been verified in more than two years